fbpx
Medical Innovation Exchange

Biohaven flunks first clinical test for rare disease drug post-Pfizer sell-off

https://www.fiercebiotech.com/clinical-data/biohaven-flunks-first-test-selling-nurtec-company-may-yet-take-data-regulators

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.